Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Characterization of hepatic markers in human Wharton's Jelly-derived mesenchymal stem cells.

Buyl K, De Kock J, Najar M, Lagneaux L, Branson S, Rogiers V, Vanhaecke T.

Toxicol In Vitro. 2014 Feb;28(1):113-9. doi: 10.1016/j.tiv.2013.06.014. Epub 2013 Jun 29.

PMID:
23820183
2.

The influence of fibroblast growth factor 4 on hepatogenic capacity of Wharton's jelly mesenchymal stromal cells.

Vojdani Z, Khodabandeh Z, Jaberipour M, Hosseini A, Bahmanpour S, Talaei-Khozani T.

Rom J Morphol Embryol. 2015;56(3):1043-50.

3.

Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential.

De Kock J, Najar M, Bolleyn J, Al Battah F, Rodrigues RM, Buyl K, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V.

Stem Cells Dev. 2012 Dec 10;21(18):3309-23. doi: 10.1089/scd.2011.0723. Epub 2012 Jul 11.

PMID:
22651824
4.

Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.

Seo MS, Park SB, Kang KS.

Cell Transplant. 2012;21(7):1493-502.

PMID:
22732242
5.

Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.

Cóndor JM, Rodrigues CE, Sousa Moreira Rd, Canale D, Volpini RA, Shimizu MH, Camara NO, Noronha Ide L, Andrade L.

Stem Cells Transl Med. 2016 Aug;5(8):1048-57. doi: 10.5966/sctm.2015-0138. Epub 2016 Jun 8.

6.

Comparison of hepatic nuclear factor-4 expression in two- and three-dimensional culture of Wharton's jelly-derived cells exposed to hepatogenic medium.

Talaei-Khozani T, Khodabandeh Z, Jaberipour M, Hosseini A, Bahmanpour S, Vojdani Z.

Rom J Morphol Embryol. 2015;56(4):1365-70.

7.

Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells.

Zhang YN, Lie PC, Wei X.

Cytotherapy. 2009;11(5):548-58. doi: 10.1080/14653240903051533.

PMID:
19657806
8.

Induction of human umbilical Wharton's jelly-derived mesenchymal stem cells toward motor neuron-like cells.

Bagher Z, Ebrahimi-Barough S, Azami M, Mirzadeh H, Soleimani M, Ai J, Nourani MR, Joghataei MT.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):987-94. doi: 10.1007/s11626-015-9921-z. Epub 2015 Jul 7.

PMID:
26148883
9.

DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.

Shivakumar SB, Bharti D, Subbarao RB, Jang SJ, Park JS, Ullah I, Park JK, Byun JH, Park BW, Rho GJ.

J Cell Biochem. 2016 Oct;117(10):2397-412. doi: 10.1002/jcb.25563. Epub 2016 Jun 23.

10.

Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.

Ma L, Feng XY, Cui BL, Law F, Jiang XW, Yang LY, Xie QD, Huang TH.

Chin Med J (Engl). 2005 Dec 5;118(23):1987-93.

PMID:
16336835
11.
12.

In vitro differentiation process of human Wharton's jelly mesenchymal stem cells to male germ cells in the presence of gonadal and non-gonadal conditioned media with retinoic acid.

Amidi F, Ataie Nejad N, Agha Hoseini M, Nayernia K, Mazaheri Z, Yamini N, Saeednia S.

In Vitro Cell Dev Biol Anim. 2015 Nov;51(10):1093-101. doi: 10.1007/s11626-015-9929-4. Epub 2015 Oct 1.

PMID:
26427713
13.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
14.

Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.

Lee HS, Kim KS, Lim HS, Choi M, Kim HK, Ahn HY, Shin JC, Joe YA.

J Cell Biochem. 2015 Feb;116(2):310-9. doi: 10.1002/jcb.24969.

PMID:
25185536
15.

Differentiation of human umbilical cord-derived mesenchymal stem cells into hepatocytes in vitro.

Zheng G, Liu Y, Jing Q, Zhang L.

Biomed Mater Eng. 2015;25(1 Suppl):145-57. doi: 10.3233/BME-141249.

PMID:
25538065
16.

Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.

He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.

Tissue Eng Part A. 2014 Apr;20(7-8):1314-24. doi: 10.1089/ten.TEA.2013.0333. Epub 2014 Mar 14.

PMID:
24279891
17.
18.

Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.

Hendijani F, Javanmard SH, Sadeghi-aliabadi H.

Tissue Cell. 2015 Jun;47(3):229-34. doi: 10.1016/j.tice.2015.01.005. Epub 2015 Jan 31.

PMID:
25779671
19.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
20.

Potential mechanisms underlying ectodermal differentiation of Wharton's jelly mesenchymal stem cells.

Jadalannagari S, Berry AM, Hopkins RA, Bhavsar D, Aljitawi OS.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):831-7. doi: 10.1016/j.bbrc.2016.08.033. Epub 2016 Aug 5.

PMID:
27501759

Supplemental Content

Support Center